Inclisiran

Leqvio 284 MG Solucion Inyectable en Jeringa Precargada

284 mg solución inyectable en jeringa precargadaSpainMarketedAuthorised 12 Nov 2024

In other countries

The same active substances on other registers, the same brand first.

LeqvioCanada · 284 MG / 1.5 ML · Solution · Novartis Pharmaceuticals Canada INCSame brand
LeqvioEuropean Union · Novartis Europharm LimitedSame brand
LeqvioItaly · Soluzione iniettabile · Novartis Europharm LimitedSame brand
Leqvio 284 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Novartis Europharm LimitedSame brand
Leqvio®Serbia · 284mg · rastvor za injekciju u napunjenom injekcionom špricu · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
Leqvio®Serbia · 284mg · rastvor za injekciju u napunjenom injekcionom špricu · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
Leqvio®Serbia · 284mg · rastvor za injekciju u napunjenom injekcionom špricu · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Inclisiran

Leqvio 284 MG Solucion Inyectable en Jeringa Precargada

284 mg solución inyectable en jeringa precargadaSpainMarketedAuthorised 12 Nov 2024

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

LeqvioSaudi Arabia · Corden Pharma S.P.A

Leqvio Solution for Injection in Prefilled Syringe 284 MG/1.5 MLSingapore · 284 mg · injection, solution · Novartis (Singapore) Pte LTD

LeqvioUnited States · 284MG BASE/1.5ML · solution · Novartis

SybravaBrazil · Novartis Biociencias S.A

Packs

Pack	Code	Status
LEQVIO 284 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada con protector de aguja	766194

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Inclisiran
Strength: 284 mg
Dosage form: solución inyectable en jeringa precargada
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 12 Nov 2024
Registration: 1201494001IP
Marketing authorisation holder: Novartis Europharm Limited
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica